Talking Points

Episode 130: The DISRUPT CAD III Trial 20.10.2021 17:00 ↓

Dean Kereiakes and C. Michael Gibson discuss intravascular lithotripsy for the treatment of severe coronary calcification.

Episode 129: The TICO-STEMI Trial 06.10.2021 8:04 ↓

Byeong-Keuk Kim and C. Michael Gibson discuss a randomized trial of ticagrelor monotherapy versus ticagrelor with aspirin in STEMI.

Episode 128: The COMPARE CRUSH Trial 22.09.2021 9:51 ↓

Georgios Vlachojannis and C. Michael Gibson discuss a randomized trial of prehospital crushed versus uncrushed prasugrel in STEMI.

Episode 127: The SOLOIST-WHF and SCORED Trials 08.09.2021 16:36 ↓

Deepak Bhatt and C. Michael Gibson discuss data on sotagliflozin in diabetes.

Episode 126: The REFLECT II Trial 25.08.2021 8:05 ↓

Jeffrey Moses and C. Michael Gibson discuss a randomized trial of cerebral embolic protection during TAVR.

Episode 125: The TIPS-3 Trial 18.08.2021 9:21 ↓

Salim Yusuf and C. Michael Gibson discuss aspirin alone and in combination with a polypill for CVD primary prevention.

Episode 124: The MITHRAS Trial 04.08.2021 3:37 ↓

Philipp Lurz and C. Michael Gibson discuss a randomized trial of ASD closure after TMVr.

Episode 123: The XIENCE 90/28 Trial 21.07.2021 10:30 ↓

Roxana Mehran and C. Michael Gibson discuss 3-month and 1-month DAPT after everolimus-eluting stents in high-bleeding-risk patients.

Episode 122: The MSTOPS Trial 07.07.2021 6:49 ↓

Steven Steinhubl and C. Michael Gibson discuss 3-year outcomes in a nationwide, randomized, pragmatic clinical trial of A-fib screening.

Episode 121: The TARGET FFR Trial 23.06.2021 8:04 ↓

Damien Collison and C. Michael Gibson discuss a randomized trial of physiology-guided PCI optimization.

Episode 120: The STRENGTH Trial 16.06.2021 11:54 ↓

A. Michael Lincoff and C. Michael Gibson discuss CV outcomes with omega-3 carboxylic acids in patients with high vascular risk and atherogenic dyslipidemia.

Episode 119: The STRENGTH Trial 02.06.2021 11:55 ↓

A. Michael Lincoff and C. Michael Gibson discuss CV outcomes with omega-3 carboxylic acids in patients with high vascular risk and atherogenic dyslipidemia.

Episode 118: The OPTIMIZE Trial 19.05.2021 10:36 ↓

Dean Kereiakes and C. MIchael Gibson discuss a randomized trial of a novel, ultra-low-profile fixed-wire DES.

Episode 117: The AHA COVID-19 CVD Registry 06.05.2021 15:36 ↓

Robert Harrington and C. Michael Gibson discuss the registry's design, implementation, and initial results.

Episode 116: The TANGO Trial 21.04.2021 6:49 ↓

Ehrin Armstrong and C. Michael Gibson discuss a randomized, dose-escalation trial of temsirolimus adventitial delivery below the knee.

Episode 115: The GALACTIC-HF Trial 07.04.2021 14:25 ↓

John Teerlink and C. Michael Gibson discuss omecamtiv mecarbil in chronic HFrEF.

Episode 114: The NACMI COVID-19 Registry 24.03.2021 28:26 ↓

Timothy Henry and C. Michael Gibson discuss outcomes from the North American registry.

Episode 113: The EXPLORER-HCM Trial 17.03.2021 10:58 ↓

Iacopo Olivotto and C. Michael Gibson discuss mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy.

Episode 112: FLASH Registry: Acute Hemodynamic Improvement 03.03.2021 6:26 ↓

C. Michael Gibson and Catalin Toma discuss acute hemodynamic improvement with percutaneous mechanical thrombectomy in a real-world pulmonary embolism population.

Episode 111: The PARALLAX Trial 17.02.2021 9:25 ↓

Burkert Pieske and C. Michael Gibson discuss sacubitril/valsartan versus individualized RAAS blockade in HFpEF.

Episode 110: The HOME-PE Trial 03.02.2021 9:26 ↓

Pierre-Marie Roy and C. Michael Gibson discuss hospitalization or outpatient management of PE.

Episode 109: The EAST-AFNET 4 Trial 20.01.2021 14:20 ↓

Paulus Kirchhof and C. Michael Gibson discuss early rhythm control therapy in patients with atrial fibrillation.

Episode 108: The BPLTTC Trial 06.01.2021 5:03 ↓

Kazem Rahimi and C. Michael Gibson discuss BP-lowering for prevention of cardiovascular events.

Episode 107: LoDoCo2 Low-Dose Colchicine in Coronary Disease 16.12.2020 7:28 ↓

Dr. Jan Cornel and Dr. C. Michael Gibson Discuss: LoDoCo2 Low-Dose Colchicine in Coronary Disease.

Episode 106: TCT Connect 2020 02.12.2020 28:45 ↓

C. Michael Gibson, Ajay Kirtane, Mamas Mamas, and Roxana Mehran talk TCT 2020.